WINTON GROUP Ltd Takes Position in Masimo Co. (MASI)
WINTON GROUP Ltd bought a new position in Masimo Co. (NASDAQ:MASI) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 48,198 shares of the medical equipment provider’s stock, valued at approximately $4,172,000. WINTON GROUP Ltd owned about 0.09% of Masimo as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently made changes to their positions in the business. Prudential Financial Inc. raised its position in shares of Masimo by 14.4% in the second quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock valued at $50,442,000 after purchasing an additional 69,810 shares during the period. State Street Corp increased its position in Masimo by 10.4% during the second quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after acquiring an additional 146,212 shares during the period. American Century Companies Inc. increased its position in Masimo by 98.0% during the second quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock worth $19,100,000 after acquiring an additional 103,656 shares during the period. D L Carlson Investment Group Inc. increased its position in Masimo by 32.4% during the second quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock worth $4,216,000 after acquiring an additional 11,315 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its stake in Masimo by 27.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock worth $99,872,000 after buying an additional 233,412 shares in the last quarter. 83.71% of the stock is currently owned by institutional investors and hedge funds.
In other news, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at $6,592,410. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Yongsam Lee sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $89.89, for a total value of $449,450.00. Following the completion of the transaction, the executive vice president now owns 74,000 shares in the company, valued at approximately $6,651,860. The disclosure for this sale can be found here. Over the last quarter, insiders sold 28,976 shares of company stock valued at $2,599,324. 13.10% of the stock is currently owned by company insiders.
Shares of Masimo Co. (NASDAQ:MASI) opened at $88.84 on Friday. Masimo Co. has a fifty-two week low of $60.31 and a fifty-two week high of $104.71. The stock has a market cap of $4,508.31, a PE ratio of 33.43, a PEG ratio of 2.94 and a beta of 0.75.
Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.17. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The business had revenue of $193.69 million for the quarter, compared to the consensus estimate of $189.01 million. During the same quarter in the previous year, the company posted $0.52 EPS. The company’s revenue was up 15.6% compared to the same quarter last year. analysts anticipate that Masimo Co. will post 2.95 EPS for the current fiscal year.
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Stock Ratings for Masimo Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Co. and related stocks with our FREE daily email newsletter.